Try a new search

Format these results:

Searched for:

person:nilsed01

in-biosketch:true

Total Results:

8


Estimating impairment from functional task performance [Meeting Abstract]

Parnandi, A; Venkatesan, A; Pandit, N; Wirtanen, A; Fokas, E; Kim, G; Nilsen, D; Schambra, H
Introduction: Quantifying upper extremity (UE) motor impairment after stroke is impractical, limiting our ability to tailor rehabilitation training in real time. The current gold-standard measure of impairment, the Fugl-Meyer Assessment (FMA), is time-consuming and requires a trained assessor. The FMA furthermore does not assess functional motions in real-world contexts, which is exactly where we aim our rehabilitation interventions. Here, we took initial steps to develop an approach to automatically quantify UE motor impairment during functional task performance.
Method(s): We studied 51 chronic stroke patients (28F:23M; 57.7 (21.3-84.3) years old; 28L:23R paretic; FMA 43.1 (8-65)).We recorded upper body motion with 9 inertial measurement units (IMUs) while patients performed the FMA and a functional task (moving an object on a horizontal 8-target array). We trained a long short-term memory (LSTM) deep learning model to estimate FMA scores from the recorded motion (training set n=40; test set n=11; 4 LSTM layers with between-layer batch normalization; IMU data windows of 4s with slide of 1s). LSTM-generated impairment scores were computed from FMA motions or from functional motions. To ascertain the accuracy of the approach, we calculated the root mean square error (RMSE) and the Spearman correlation coefficient (rho) between the LSTM scores and the FMA scores from a trained expert. We also examined whether the performance of particular classes of functional primitives (i.e. reach, transport, or reposition) would be sufficient to accurately estimate impairment.
Result(s): Using motions from the FMA performance, our approach estimated FMA scores within 1.1 points of a trained assessor. Using motions from the functional task performance, our approach estimated FMA scores within 1.6 points. Correlation values between the FMA scores and LSTM scores were rho = 0.98 for FMA motions and rho = 0.96 for functional motions. Among the three functional primitives, reaches were the most informative for estimating the impairment scores (RMSE: 1.9 points), followed by transports (RMSE: 2.1 points), and repositions (RMSE: 2.8 points).
Discussion(s): We present a new approach that uses sensor-based motion capture and deep learning to automatically estimate UE motor impairment. This approach has high accuracy and shows high concurrent validity with the FMA, even when it assesses unrelated functional motions. Thus, it may be possible to directly measure impairment from performance of real-world functional tasks, which the FMA does not offer. Estimating impairment during stroke rehabilitation would enable clinicians to tailor treatment strategy in real time.
EMBASE:636605242
ISSN: 1552-6844
CID: 5078502

Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06

Anger, Holly A; Dworkin, Felicia; Sharma, Saarika; Munsiff, Sonal S; Nilsen, Diana M; Ahuja, Shama D
Rationale Linezolid may be effective for the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB); however, serious adverse events are common and there is little information on the management of these toxicities. METHODS: We retrospectively reviewed public health and medical records of 16 MDR TB patients, including 10 patients with XDR TB, who were treated with linezolid in New York City between January 2000 and December 2006, to determine treatment outcomes and describe the incidence, management and predictors of adverse events. RESULTS: Linezolid was added to MDR TB regimens for a median duration of 16 months (range: 1-29). Eleven patients (69%) completed treatment, four (25%) died and one (6%) discontinued treatment without relapse. Myelosuppression occurred in 13 (81%) patients a median of 5 weeks (range: 1-11) after starting linezolid, gastrointestinal adverse events occurred in 13 (81%) patients after a median of 8 weeks (range: 1-57) and neurotoxicity occurred in seven (44%) patients after a median of 16 weeks (range: 10-111). Adverse events were managed by combinations of temporary suspension of linezolid, linezolid dose reduction and symptom management. Five (31%) patients required eventual discontinuation of linezolid. Myelosuppression was more responsive to clinical management strategies than was neurotoxicity. Leucopenia and neuropathy occurred more often in males and older age was associated with thrombocytopenia (P < 0.05). CONCLUSIONS: The majority of MDR TB patients on linezolid had favourable treatment outcomes, although treatment was complicated by adverse events that required extensive clinical management.
PMID: 20150181
ISSN: 0305-7453
CID: 952152

Cocaine cue versus cocaine dosing in humans: evidence for distinct neurophysiological response profiles

Reid, Malcolm S; Flammino, Frank; Howard, Bryant; Nilsen, Diana; Prichep, Leslie S
Subjective, physiological and electroencephalographic (EEG) profiles were studied in cocaine dependent study participants in response to cocaine cue exposure or a dose of smoked cocaine. Both stimuli increased subjective ratings of cocaine high and craving, enhanced negative affect, and boosted plasma ACTH and skin conductance levels. However, cocaine dose produced a greater increase in high and a more prolonged increase in plasma ACTH, while cocaine cue produced a decline in skin temperature. Both stimuli produced increases in absolute theta, alpha and beta EEG power over the prefrontal cortex. However, interhemispheric EEG coherence over the prefrontal cortex decreased during cocaine cue exposure but increased following cocaine dose. Moreover, correlation analysis of subjective, physiological and EEG responding to cocaine cue and dose revealed distinct profiles. Delta and theta activity were associated with negative affect during cocaine cue exposure, but were associated with cocaine craving and reward following cocaine dosing. In both conditions, alpha activity was marker for anxiousness but not high. These data demonstrate similar subjective, physiological responding in clinical laboratory states of cocaine craving and reward. However, differences in EEG response profiles, and their relationship to function, indicate distinct neurophysiological mediators of cocaine craving and reward within the prefrontal cortex
PMCID:2580734
PMID: 18674556
ISSN: 0091-3057
CID: 92848

Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans

Reid, Malcolm S; Flammino, Frank; Howard, Bryant; Nilsen, Diana; Prichep, Leslie S
Quantitative electroencephalographic (qEEG) profiles were studied in cocaine-dependent patients in response to an acute, single-blind, self-administered dose of smoked cocaine base (50 mg) vs placebo. qEEG data were averaged using neurometric analytical methods and the spectral power of each primary bandwidth was computed and topographically imaged. Additional measures included cocaine-induced high, craving, and related subjective ratings, heart rate, blood pressure, and plasma cortisol and homovanillic acid levels. In all, 13 crack cocaine-dependent subjects were tested. Cocaine produced a rapid increase in subjective ratings of cocaine high and good drug effect, and a more persistent increase in cocaine craving and nervousness. Cocaine also produced a rapid rise in heart rate and a prolonged increase in plasma cortisol. Placebo, administered in the context of cocaine cues and dosing expectations, had no cocaine-like subjective or physiological effects. Cocaine produced a rapid increase in absolute theta, alpha, and beta power over the prefrontal cortex (FP1, FP2), lasting up to 25 min after dosing. The increase in theta power was correlated with good drug effect, and the increase in alpha power was correlated with nervousness. Cocaine also produced a similar increase in delta coherence over the prefrontal cortex, which was positively correlated with plasma cortisol, and negatively correlated with nervousness. Placebo resulted in an increase in alpha power over the prefrontal cortex. These data demonstrate the involvement of prefrontal cortex in the qEEG response to acute cocaine. Evidence indicates slow wave qEEG, delta and theta activity, involvement in the rewarding properties of cocaine
PMID: 16192989
ISSN: 0893-133x
CID: 64194

Conditioned and unconditioned cocaine stimulus effects in cocaine abusers: Similar neurophysiological and subjective response patterns [Meeting Abstract]

Reid, MS; Flammino, F; Prichep, L; Howard, B; Gianotti, R; Kreek, MJ; Nilsen, D
ISI:000220690500069
ISSN: 0803-9488
CID: 46658

Regulation of expression of granulocyte-macrophage colony-stimulating factor in human bronchial epithelial cells: roles of protein kinase C and mitogen-activated protein kinases

Reibman J; Talbot AT; Hsu Y; Ou G; Jover J; Nilsen D; Pillinger MH
GM-CSF has a major role in the immune and inflammatory milieu of the airway. Airway epithelial cells (AEC) are among the first targets of environmental stimuli and local cytokines, in response to which they can produce GM-CSF. The regulation of GM-CSF is only minimally understood in AEC. We hypothesized that GM-CSF expression in AEC would result from activation of protein kinase C (PKC) and subsequent activation of the extracellular signal-regulated kinase (MAPKerk1/2) pathway, so we investigated signal transduction pathways in human primary culture bronchial epithelial cells (HBECs). TNF-alpha, IL-1beta, and PMA induced the release of GM-CSF in HBECs. The robust response to PMA was not detected in SV40 adenovirus-transformed normal human bronchial epithelial cells (BEAS-2B). PMA and TNF-alpha stimulation of GM-CSF required activation of PKC (inhibition by staurosporine and bisindolylmaleimide I). GM-CSF expression was up-regulated by a nonphorbol PKC activator, but not by an inactive PMA analogue. PMA-induced GM-CSF production in HBECs did not require a Ca2+ ionophore and was not inhibited by cyclosporin A. Activation of MAPKerk1/2 via PKC was associated with and was required for GM-CSF production induced by PMA and TNF-alpha. The data demonstrate regulation of GM-CSF in HBECs by PKC pathways converging on the MAPKerk1/2 pathway and further define cell-specific regulation critical for local airway responses
PMID: 10903772
ISSN: 0022-1767
CID: 11588

Wound healing is accelerated by agonists of adenosine A2 (G alpha s-linked) receptors

Montesinos MC; Gadangi P; Longaker M; Sung J; Levine J; Nilsen D; Reibman J; Li M; Jiang CK; Hirschhorn R; Recht PA; Ostad E; Levin RI; Cronstein BN
The complete healing of wounds is the final step in a highly regulated response to injury. Although many of the molecular mediators and cellular events of healing are known, their manipulation for the enhancement and acceleration of wound closure has not proven practical as yet. We and others have established that adenosine is a potent regulator of the inflammatory response, which is a component of wound healing. We now report that ligation of the G alpha s-linked adenosine receptors on the cells of an artificial wound dramatically alters the kinetics of wound closure. Excisional wound closure in normal, healthy mice was significantly accelerated by topical application of the specific A2A receptor agonist CGS-21680 (50% closure by day 2 in A2 receptor antagonists. In rats rendered diabetic (streptozotocin-induced diabetes mellitus) wound healing was impaired as compared to nondiabetic rats; CGS-21680 significantly increased the rate of wound healing in both nondiabetic and diabetic rats. Indeed, the rate of wound healing in the CGS-21680-treated diabetic rats was greater than or equal to that observed in untreated normal rats. These results appear to constitute the first evidence that a small molecule, such as an adenosine receptor agonist, accelerates wound healing in both normal animals and in animals with impaired wound healing
PMCID:2199104
PMID: 9348321
ISSN: 0022-1007
CID: 7954

Biomarkers of lung inflammation in recreational joggers exposed to ozone

Kinney PL; Nilsen DM; Lippmann M; Brescia M; Gordon T; McGovern T; El-Fawal H; Devlin RB; Rom WN
Humans exhibit an acute inflammatory response in the lungs after controlled laboratory exposure to ozone. The present study was designed to test whether biomarkers of inflammation are detectable in humans exposed to ozone and associated copollutants under natural conditions outdoors. Bronchoscopy with bronchoalveolar lavage (BAL) was carried out on 19 normal volunteer joggers from Governors Island, NY, who exercised in the afternoon during the 1992 summer (S1) season. Fifteen subjects were retested during the following, low ozone, winter season (W). The BAL protocol involved an initial instillation of 20 ml saline followed by four sequential 50-ml saline washes carried out in both the right middle lobe and the lingula. The eight 50-ml samples were pooled as the 'alveolar' sample. Analyses performed on the alveolar lavage samples included cell differentials, release of IL-8, TNF-alpha, and reactive oxygen species (ROS) by pooled cells, and levels of IL-8, protein, LDH, fibronectin, alpha1-antitrypsin (alpha1-AT), complement fragment 3a (C3a), and prostaglandin E2 (PGE2) in lavage fluids. Release of ROS by stimulated BAL cells was lower in S1 than in W (p = 0.03). In contrast, LDH levels in BAL fluids were 2-fold higher in S1 than in W (p = 0.02), as were IL-8 (p = 0.12) and PGE2 (p = 0.06). These results suggest a possible ongoing inflammatory response in the lungs of recreational joggers exposed to ozone and associated copollutants during the summer months
PMID: 8912760
ISSN: 1073-449x
CID: 12497